Tessera
Folgen

Dr. Smita Divyaveer, MD, DM Nephrology

@divyaveerssneph.bsky.social

Nephrologist and transplant Physician 🫶 🫘|Faculty 🇮🇳 🆒Nerd |FASN |🌍 #ISNGKHA Fellow and Mentor ☀️Academics|Clinics|Research & #NephJC editorial intern Tweets: own views

67 Posts438 Follower572 Folgt
Swapnil Hiremath 🍁🇨🇦@hswapnil.medsky.social · 2w ago

The #NephJC interns @manoleaandreea.bsky.social and @divyaveerssneph.bsky.social dissect the FINDCKD study from @brendonneuen.bsky.social et al www.nephjc.com/news/2026/7/...

Beyond Diabetic Kidney Disease: FIND-ing Finerenone's Next Role — NephJC

FIND-CKD extends finerenone beyond diabetic kidney disease, showing slower eGFR decline and sustained albuminuria reduction in non-diabetic CKD. While the benefits are modest and cardiovascular effect...

nephjc.com

Nephrology Journal Club@nephjc.bsky.social · 2w ago

👀 Seek and you shall FIND 🔎 #ERA26 #NephSky FIND-CKD asks if finerenone is beneficial in patients with non-diabetic CKD. Blog by @manoleaandreea.bsky.social & @divyaveerssneph.bsky.social www.nephjc.com/news/2026/7/6/find-ckd

Beyond Diabetic Kidney Disease: FIND-ing Finerenone's Next Role — NephJC

FIND-CKD extends finerenone beyond diabetic kidney disease, showing slower eGFR decline and sustained albuminuria reduction in non-diabetic CKD. While the benefits are modest and cardiovascular effect...

nephjc.com

Dr. Smita Divyaveer, MD, DM Nephrology@divyaveerssneph.bsky.social · 2mo ago

📢Honored and humbled to be selected for #NephJC Editorial Internship 🙏2026-2027 As a long time admirer of NephJC and a Clinican - Researcher, I'm super excited to learn, contribute, and engage with this outstanding #Nephrology community 🫘💫 #Nephbluesky #Nephsky

Nephrology Journal Club@nephjc.bsky.social · 2mo ago

✨Exciting news #NephtSky The new #NephJC editorial interns are here! 📢Give them a follow and make them feel at home 👉 @drbarbateba.bsky.social @ancast13.bsky.social @kiddokidney.bsky.social @andrewdelaat.bsky.social @farahwehbe92.bsky.social 👇👇 www.nephjc.com/news/2025/6/...

Dr. Smita Divyaveer, MD, DM Nephrology@divyaveerssneph.bsky.social · last yr.

🆕Once-Monthly💉 Maridebart Cafraglutide for the Treatment of Obesity — A Phase 2 Trial | New England Journal of Medicine www.nejm.org/doi/full/10.... combines GLP-1 receptor agonism & glucose-dependent insulinotropic polypeptide (GIP) receptor antagonism #Nephrology #Nephsky #Nephbluesky #Medsky

Once-Monthly Maridebart Cafraglutide for the Treatment of Obesity — A Phase 2 Trial | NEJM

Maridebart cafraglutide (known as MariTide) is a long-acting peptide–antibody conjugate that combines glucagon-like peptide-1 receptor agonism and glucose-dependent insulinotropic polypeptide recep...

nejm.org

Dr. Smita Divyaveer, MD, DM Nephrology@divyaveerssneph.bsky.social · last yr.

Chromogranin A is a curious entity! Thank you @drsumanbehera.bsky.social @myadla.bsky.social for the extraordinary #ECNeph case Chromogranin A Nephropathy / tubulopathy bmcnephrol.biomedcentral.com/articles/10.... #Nephsky #Nephbluesky

Serum chromogranin A correlated with albuminuria in diabetic patients and is associated with early diabetic nephropathy - BMC Nephrology

Background The kidney is the main site for the removal of chromogranin A (CgA). Previous studies have found that patients with renal impairment displayed elevated concentrations of CgA in plasma and t...

bmcnephrol.biomedcentral.com

ISNkidneycare@theisn.org · last yr.

19/n #ECNeph @drsumanbehera.bsky.social @myadla.bsky.social @drpriyajohn.bsky.social @theisn.org Check this informative slide on tubular involvement in CgAN

Dr. Smita Divyaveer, MD, DM Nephrology@divyaveerssneph.bsky.social · last yr.

Thank you @arvindcanchi.bsky.social for ur kind words 🙏 My team's work on #kidney function in #liver disease is 🎯 to completion. Hoping to publish final results from our @icmr.bsky.social funded study soon. #ISNWCN #Hepatonephrology #Nephrology #Nephsky #Nephbluesky #Medsky 👀results of our pilot 📃

https://www.jcehepatology.com/article/S0973-6883(24)01131-9/abstract
Arvind (Canchi) Conjeevaram@arvindcanchi.bsky.social · last yr.

Excellent talk at the World Congress of Nephrology today by @divyaveerssneph.bsky.social on the measurement of Screat in cirrhosis pts. She laid emphasis on the use of the Royal Free Hospital formula for egfr (or the combined Screat & Cystatin C ckdepi formula) based on her study. #ISNWCN

Dr. Smita Divyaveer, MD, DM Nephrology@divyaveerssneph.bsky.social · 2y ago

docs.google.com/forms/d/e/1F...

Renal function in cirrhosis: A Questionnaire

This short survey will take about 2 to 3 mins to complete. Cirrhosis-related kidney dysfunction presents significant challenges for clinicians. This survey explores how healthcare professionals asses...

docs.google.com

Dr. Smita Divyaveer, MD, DM Nephrology@divyaveerssneph.bsky.social · 2y ago

📢 Nephrologists, Hepatologists and Physicians dealing with #kidney #disease in #liver cirrhosis. Please give 5 mins of your valuable time to fill this survey. It'll help us understand current practices #Nephbluesky #Nephsky #Medsky Results will be present @ #WCN2025 @myadla.bsky.social @theisn

https://docs.google.com/forms/d/e/1FAIpQLSdQet0SKAv4W0iLQUNAVu43WuQSS3qWdnFYIKnz6m0jWDvKAQ/viewform
Juan Carlos Q Vélez, MD@juancarlosqvelez.bsky.social · 2y ago

1/n HydrANCAzine (hydralazine-induced ANCA-associated vasculitis has turn into an important cause of crescentic glomerulonephritis. Wonder how does hydralazine do it? Here is a tweetorial (BlueSkytorial?). I’ll start with an animation that summarizes and simplifies a proposed mechanism.